• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Philip Morris International to Fund Law Clinics in Expansion of the Organization's U.S. Veterans Program

    6/12/24 8:00:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $PM alert in real time by email

    New White Paper Provides Recommendations on Closing Gaps That Can Exacerbate the Challenge of Transitioning Back to Civilian Life

    Philip Morris International (PMI) today announced a renewed commitment of over $3 million to support the veterans community nationwide this year. The strategy is informed by the findings of a newly published white paper, "Serving Those Who Served," which shares first-person insights from veterans across the country and details PMI's commitment to empower and positively impact the lives of veterans and their families. Actions include an initial $850,000 awarded by PMI to legal clinics at select law schools as part of a coordinated initiative supporting military veterans in their transition to civilian life, as well as additional funding for local and national organizations improving the lives of veterans. This scaled-up commitment reflects PMI's intensified focus on the veterans community as the company further establishes itself in the U.S. market, which began with its 2022 acquisition of Swedish Match.

    "As a company, we are throwing our weight behind serving the men and women who have raised their hands to serve in our armed forces, some of whom require additional support as they reintegrate into civilian life. This is a cause that resonates strongly among our employees," said Marian Salzman, Senior Vice President & Chief Corporate Citizenship Officer, PMI. "They are eager to make a difference in the lives of those who have sacrificed in support of our nation, its values, and its allies."

    Salzman added, "PMI's latest round of contributions is part of a broader veterans support effort that we have been implementing since 2022. We anticipate additional grants as we expand our U.S. footprint, including to local organizations such as Colorado Goldstar Mothers, and will continue to connect directly with veterans and their advocates to explore our best avenues of assistance."

    The U.S. government has established a robust support system for military veterans. Nevertheless, gaps persist—and PMI believes it and other organizations should play a role in helping fill those gaps. Under its expanded veterans support program, PMI is funding clinics at select law schools to offer area veterans access to much-needed legal support, including help navigating the rules and regulations that can make it difficult for veterans to receive the benefits to which they're entitled. Founding beneficiaries of this initiative in 2024 include planned partnerships with:

    • Rocky Mountain Veterans Advocacy Project (Aurora, CO)
    • Veterans' Advocacy Law Clinic, University of Arizona James E. Rogers College of Law (Tucson, AZ)
    • Veterans and Servicemembers Legal Clinic, University of Florida Levin College of Law (Gainesville, FL)

    "Every dollar we receive helps us reach more veterans and remove legal barriers that hinder the transition from military service to civilian life," said Kristine Huskey, Clinical Professor of Law and Director of the Veterans' Advocacy Law Clinic at the University of Arizona College of Law. "Through the law clinic, we're working to ensure that the men and women who served our nation can overcome legal obstacles and have full access to the benefits they've earned, including disability compensation. Support also increases our ability to train more law students—the next generation of lawyers—on veterans issues."

    Building on a five-year partnership, PMI is also amping up its support of the Bob Woodruff Foundation, a leading organization working to ensure U.S. military veterans secure stable and successful futures.

    "Philip Morris International has been a long-standing and highly valued partner of the foundation. Their steadfast support has touched the lives of thousands of veterans and their families. This latest commitment will allow us to further scale our efforts as we work to create bright futures for those who have contributed so much," said Anne Marie Dougherty, CEO, Bob Woodruff Foundation.

    In 2022–2023, PMI donated well in excess of $1 million to organizations working on behalf of U.S. veterans and active service members. This support includes a recent collaboration with Iraq and Afghanistan Veterans of America (IAVA) to improve the lives of post-9/11 U.S. veterans. In 2023, PMI provided a $500,000 grant to IAVA, with $100,000 directly supporting IAVA's initiatives and the remaining $400,000 distributed among several sub-grantees: Active Heroes, American Corporate Partners, Elizabeth Dole Foundation, Forgotten Not Gone, Lady Veterans Connect, and Purple Heart Homes.

    Read more about PMI's veterans-focused efforts and download the "Serving Those Who Served" white paper here.

    Philip Morris International, U.S.: Delivering a Smoke-Free Future

    Philip Morris International (PMI), U.S. is working to deliver a smoke-free future. Since 2008, PMI has invested $12.5 billion globally to develop, scientifically substantiate, and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. In 2022, PMI acquired Swedish Match—a leader in oral nicotine delivery—creating a global smoke-free champion led by the companies' IQOS and ZYN brands. The U.S. Food and Drug Administration has authorized versions of PMI's IQOS Platform 1 devices and consumables and Swedish Match's General snus as Modified Risk Tobacco Products. For more information, please visit www.pmi.com/us/ and www.pmiscience.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240612900548/en/

    Get the next $PM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PM

    DatePrice TargetRatingAnalyst
    1/20/2026$180.00Buy → Hold
    Jefferies
    7/9/2025$220.00Buy
    Jefferies
    5/22/2025$195.00Buy
    Needham
    4/25/2025$170.00Sell → Neutral
    UBS
    3/14/2025Hold → Buy
    Argus
    1/16/2025$140.00Overweight
    Morgan Stanley
    3/5/2024Buy → Hold
    Argus
    2/13/2024Sell → Hold
    Societe Generale
    More analyst ratings

    $PM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Philip Morris International downgraded by Jefferies with a new price target

    Jefferies downgraded Philip Morris International from Buy to Hold and set a new price target of $180.00

    1/20/26 9:10:49 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Jefferies resumed coverage on Philip Morris International with a new price target

    Jefferies resumed coverage of Philip Morris International with a rating of Buy and set a new price target of $220.00

    7/9/25 8:31:10 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Needham initiated coverage on Philip Morris International with a new price target

    Needham initiated coverage of Philip Morris International with a rating of Buy and set a new price target of $195.00

    5/22/25 8:27:06 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    $PM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Group Controller Dobrowolski Reginaldo covered exercise/tax liability with 22 shares (SEC Form 4)

    4 - Philip Morris International Inc. (0001413329) (Issuer)

    3/9/26 4:23:03 PM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Group Chief Financial Officer Babeau Emmanuel covered exercise/tax liability with 2,228 shares and sold $6,138,418 worth of shares (33,800 units at $181.61), decreasing direct ownership by 18% to 164,463 units (SEC Form 4)

    4 - Philip Morris International Inc. (0001413329) (Issuer)

    2/20/26 4:01:45 PM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Group Controller Dobrowolski Reginaldo covered exercise/tax liability with 250 shares and sold $1,100,880 worth of shares (6,000 units at $183.48), decreasing direct ownership by 20% to 21,182 units (SEC Form 4)

    4 - Philip Morris International Inc. (0001413329) (Issuer)

    2/20/26 4:01:38 PM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    $PM
    SEC Filings

    View All

    SEC Form DEFA14A filed by Philip Morris International Inc

    DEFA14A - Philip Morris International Inc. (0001413329) (Filer)

    3/31/26 2:03:06 PM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Philip Morris International Inc

    SCHEDULE 13G/A - Philip Morris International Inc. (0001413329) (Subject)

    3/27/26 11:22:44 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form DEFA14A filed by Philip Morris International Inc

    DEFA14A - Philip Morris International Inc. (0001413329) (Filer)

    3/26/26 6:06:32 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    $PM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    IQOS and Devialet Introduce "Soundsorial Design" Collaboration

    Exhibition and capsule collection drop at Milan Design Week 2026 Philip Morris International (NYSE:PM) today announced a collaboration between IQOS – the number 1 tobacco heating system1, and Devialet – the French acoustic engineering company, launching "Soundsorial Design" at Milan Design Week 2026. The immersive exhibition is an ethereal landscape of water and light, where sound, movement, and voice become visible across an ever‑changing immersive canvas. A space to push experiential boundaries, where visitors are invited to explore their own frequency as sound transforms into sight. The collaboration celebrates self-expression while connecting a community of over 35 million IQOS user

    4/20/26 4:00:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Philip Morris International Announces U.S. FDA Reauthorization of IQOS as a Modified Risk Tobacco Product

    A pioneer in smoke-free tobacco products, Philip Morris International is the only company that has received modified risk tobacco product authorizations for heated tobacco products. In their order, FDA concluded that: "Scientific studies have shown that switching completely from conventional cigarettes to the IQOS system significantly reduces your body's exposure to harmful or potentially harmful chemicals" The U.S. Food and Drug Administration (FDA) announced that it has authorized the renewal of modified risk tobacco product (MRTP) orders previously granted to PMI for two versions of the IQOS device and three variants of the tobacco consumables, commercialized under the HEETS brand. T

    4/17/26 5:43:00 PM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    PMI U.S. Calls for Science‑Based Policy and Credible, Open Dialogue to Accelerate America's Smoke‑Free Future

    WASHINGTON, April 17, 2026 /PRNewswire/ -- Philip Morris International's U.S. businesses (PMI U.S.) brought a pointed message to Washington this week: America's transition away from combustible cigarettes is being held back—not by a lack of science, but by a lack of urgency. The call comes on the heels of Technovation, PMI's global science and innovation summit held in Washington, D.C., where policymakers, scientists, business leaders, public health advocates and the media examined the persistent challenges of cigarette smoking and the urgent need for evidence-based solutions. Central to those discussions: new research in the U.S. showing that a fundamental misperception among American legal

    4/17/26 8:00:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    $PM
    Financials

    Live finance-specific insights

    View All

    Philip Morris International Declares Regular Quarterly Dividend of $1.47 Per Share

    Regulatory News: The Board of Directors of Philip Morris International Inc. (NYSE:PM) today declared a regular quarterly dividend of $1.47 per common share, payable on April 13, 2026, to shareholders of record as of March 19, 2026. The ex-dividend date is March 19, 2026. For more details on stock, dividends and other information, see www.pmi.com/dividend. Philip Morris International: A Global Smoke-Free Champion Philip Morris International is a leading international consumer goods company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company's current product portfolio primarily

    3/5/26 7:00:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Philip Morris International Presents at 2026 CAGNY Conference; Reaffirms 2026 Full-Year Forecast

    Regulatory News: Philip Morris International Inc.'s (PMI) (NYSE:PM) Group CEO PMI, Jacek Olczak, and Group Chief Financial Officer, Emmanuel Babeau, will address investors today at the 2026 Consumer Analyst Group of New York (CAGNY) Conference at approximately 10:00 a.m. ET. The live webcast and presentation slides will be available here. The webcast replay will be available at the same link for six months after the event. The webcast may also be accessed on mobile devices by downloading PMI's Investor Relations App at www.pmi.com/irapp. The presentation will cover: How a transformed PMI is leading the industry in an evolving operating environment; The success and future opportu

    2/18/26 7:00:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Philip Morris International Reports 2025 Fourth-Quarter & Full-Year Results

    Delivers Full Year 2025 Reported Diluted EPS of $7.26 compared to $4.52 in 2024 and Adjusted Diluted EPS of $7.54, Representing Growth of 14.8%, and 14.2% on a Currency-Neutral Basis; Provides 2026 - 2028 Growth Targets Regulatory News: Philip Morris International Inc. (PMI) (NYSE:PM) today announces its 2025 fourth quarter results.1 "We achieved another remarkable year of results in 2025, with a fifth consecutive year of volume growth, net revenues surpassing $40 billion, including close to $17 billion from our smoke-free business, and very good operating margin expansion," said Jacek Olczak, Group CEO PMI. "With excellent results in 2024 and 2025, we have delivered our three-year CA

    2/6/26 6:59:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    $PM
    Leadership Updates

    Live Leadership Updates

    View All

    Philip Morris International Opens Dialogue on the Future of Human Cognition as a Defining Frontier in the Age of AI

    The paper calls for global debate to ensure AI enhances—rather than diminishes—uniquely human strengths in an increasingly automated world Philip Morris International Inc. (NYSE:PM) today released a new white paper, "Human Cognition: The Next Frontier?", inviting leaders across business, policy, and academia to join a global conversation on the evolving role of human cognition as artificial intelligence transforms work, society, and the economy. The white paper explores how human capabilities such as - critical thinking, creativity and adaptability - are poised to become the "superskill" of the future, driving progress in an era of human-machine collaboration. As AI automates routine ta

    1/20/26 5:03:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Molex, a Parent to Phillips Medisize, Announces Agreement to Acquire the Vectura Group Limited, Expanding Its Drug Delivery Capabilities in Inhalation

    Pharmaceutical customers and patients to benefit from the combined design, development and manufacturing services of Vectura and Phillips Medisize Phillips Medisize to add a market-leading position in inhalation combination product development to its existing suite of drug delivery device design capabilities Vectura employees to join a large global company, dedicated to improving patients' lives through innovative products and world class quality and manufacturing capabilities Molex, a parent to Phillips Medisize, a leader in the design, engineering and manufacturing of pharmaceutical drug delivery, in vitro diagnostic and medtech devices, announced that, through its affiliate Molex

    9/17/24 9:11:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Philip Morris International Names New External Affairs Leader

    Philip Morris International Inc. (PMI) (NYSE:PM) is pleased to announce the appointment of Christos Harpantidis to the position of Senior Vice President, External Affairs effective May 1, 2024. In his new role, Mr. Harpantidis will report to the company's CEO, Jacek Olczak. "Christos is an experienced business leader with a proven track record of engaging society on the benefits of tobacco harm reduction and risk-proportionate regulation for smoke-free products," said CEO Jacek Olczak. "He has been instrumental in building our smoke-free business in Greece and the South East Europe Area as we evolve away from cigarettes. I'm looking forward to working with Christos and excited to see what

    3/26/24 5:48:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    $PM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Philip Morris International Inc (Amendment)

    SC 13G/A - Philip Morris International Inc. (0001413329) (Subject)

    2/9/24 6:21:26 PM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G/A filed by Philip Morris International Inc (Amendment)

    SC 13G/A - Philip Morris International Inc. (0001413329) (Subject)

    2/9/24 6:05:54 PM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G/A filed by Philip Morris International Inc (Amendment)

    SC 13G/A - Philip Morris International Inc. (0001413329) (Subject)

    1/29/24 3:26:29 PM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care